506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma

Clinical trial NCT00005982 · TERMINATED

Trial details

NCT number: NCT00005982
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome

Start date: 2000-04-01
Primary completion: 2004-07-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.